Literature DB >> 28523440

Assessing and Modifying Coronary Artery Disease Risk in Women.

Amy Sarma1, Nandita S Scott2.   

Abstract

OPINION STATEMENT: Despite continued advances in the field, cardiovascular disease remains the leading cause of death in women in the USA with an annual mortality rate that has remained higher for women as compared to men. The factors leading to this sex difference remain incompletely understood. Likely contributors include atypical symptoms at presentation and lack of recognition of cardiovascular risk by women and their providers alike. In addition, women have a higher burden of comorbidities at the time of disease diagnosis and can have differential pathophysiological mechanisms of their acute events. Women also can develop unique cardiovascular risk factors such as preeclampsia and hypertensive disorders of pregnancy. As a result, when women present with symptoms, even atypical, healthcare providers should increase their index level of suspicion for cardiovascular disease. Even after diagnosis, women are less likely to receive guideline-directed medical therapies and be referred for coronary angiography or cardiac rehabilitation. Thus, greater awareness of and research into the aspects of coronary disease that remain unique to women is critical, as women presenting with coronary disease continue to receive disparate care as compared to men. Improvements in awareness and care and new research avenues may reduce the incidence and complications of cardiovascular disease among women.

Entities:  

Keywords:  Coronary artery disease; Prevention; Treatment; Women

Year:  2017        PMID: 28523440     DOI: 10.1007/s11936-017-0554-2

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  98 in total

1.  Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction: The VIRGO Study.

Authors:  Erica C Leifheit-Limson; Gail D'Onofrio; Mitra Daneshvar; Mary Geda; Héctor Bueno; John A Spertus; Harlan M Krumholz; Judith H Lichtman
Journal:  J Am Coll Cardiol       Date:  2015-11-03       Impact factor: 24.094

Review 2.  2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Authors:  Donald M Lloyd-Jones; Pamela B Morris; Christie M Ballantyne; Kim K Birtcher; David D Daly; Sondra M DePalma; Margo B Minissian; Carl E Orringer; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2016-04-01       Impact factor: 24.094

3.  Spontaneous coronary artery dissection: revascularization versus conservative therapy.

Authors:  Marysia S Tweet; Mackram F Eleid; Patricia J M Best; Ryan J Lennon; Amir Lerman; Charanjit S Rihal; David R Holmes; Sharonne N Hayes; Rajiv Gulati
Journal:  Circ Cardiovasc Interv       Date:  2014-11-18       Impact factor: 6.546

4.  Is there a difference in the diagnostic accuracy of computed tomography coronary angiography between women and men?

Authors:  Anoeshka S Dharampal; Alexia Rossi; Stella L Papadopoulou; Annick C Weustink; Eric Boersma; Koen Nieman; Chia-Hui Chen; Marcel Dijkshoorn; Nico R Mollet; Gabriel P Krestin; Pim J de Feyter
Journal:  Coron Artery Dis       Date:  2011       Impact factor: 1.439

5.  Gender differences in the management and clinical outcome of stable angina.

Authors:  Caroline Daly; Felicity Clemens; Jose L Lopez Sendon; Luigi Tavazzi; Eric Boersma; Nicholas Danchin; Francois Delahaye; Anselm Gitt; Desmond Julian; David Mulcahy; Witold Ruzyllo; Kristian Thygesen; Freek Verheugt; Kim M Fox
Journal:  Circulation       Date:  2006-01-31       Impact factor: 29.690

6.  Cardiac rehabilitation in African Americans: evidence for poorer outcomes compared with whites, especially in women and diabetic participants.

Authors:  Dominic Johnson; Matthew Sacrinty; Hardik Mehta; Christopher Douglas; Connie Paladenech; Killian Robinson
Journal:  Am Heart J       Date:  2014-10-02       Impact factor: 4.749

7.  Cerebrovascular, cardiovascular and renal hypertensive disease after hypertensive disorders of pregnancy.

Authors:  S A M Schokker; M F Van Oostwaard; E M Melman; J P Van Kessel; M I Baharoglu; Y B W E M Roos; L Vogt; R J De Winter; B W Mol; W Ganzevoort
Journal:  Pregnancy Hypertens       Date:  2015-06-22       Impact factor: 2.899

8.  ACOG Committee Opinion No. 565: Hormone therapy and heart disease.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-06       Impact factor: 7.661

Review 9.  American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease--the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction].

Authors:  Jennifer H Mieres; Leslee J Shaw; Robert C Hendel; D Douglas Miller; Robert O Bonow; Daniel S Berman; Gary V Heller; Jennifer H Mieres; C Noel Bairey-Merz; Daniel S Berman; Robert O Bonow; Jean M Cacciabaudo; Gary V Heller; Robert C Hendel; Maria C Kiess; D Douglas Miller; Donna M Polk; Leslee J Shaw; Paola E Smanio; Mary N Walsh
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

10.  Use of diagnostic coronary angiography in women and men presenting with acute myocardial infarction: a matched cohort study.

Authors:  Louise Hougesen Bjerking; Kim Wadt Hansen; Mette Madsen; Jan Skov Jensen; Jan Kyst Madsen; Rikke Sørensen; Søren Galatius
Journal:  BMC Cardiovasc Disord       Date:  2016-06-01       Impact factor: 2.298

View more
  2 in total

1.  Are women more susceptible to ischemic heart disease compared to men? A literature overview.

Authors:  Masoud Majidi; Vahid Eslami; Pardis Ghorbani; Mahnoosh Foroughi
Journal:  J Geriatr Cardiol       Date:  2021-04-28       Impact factor: 3.189

2.  Roles of Nitric Oxide and Prostaglandins in the Sustained Antihypertensive Effects of Acanthospermum hispidum DC. on Ovariectomized Rats with Renovascular Hypertension.

Authors:  Rhanany Alan Calloi Palozi; Maysa Isernhagen Schaedler; Cleide Adriane Signor Tirloni; Aniely Oliveira Silva; Francislaine Aparecida Dos Reis Lívero; Roosevelt Isaias Carvalho Souza; Ariany Carvalho Dos Santos; Thiago Bruno Lima Prando; Lauro Mera de Souza; Arquimedes Gasparotto Junior
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-20       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.